Biotech Stocks With Pessimistic Trend – ImmunoCellular Therapeutics (IMUC … – Wall Street Observer

Biotech Stocks With Pessimistic Trend – ImmunoCellular Therapeutics (IMUC
Wall Street Observer
The company, on February 12, 2015, reported that it has priced an underwritten public offering of an aggregate of 26,650,000 shares of its common stock at a price to the public of $0.60 per share, and warrants to purchase up to an aggregate of 18,655
Mix Stock In Focus: Assurant Inc. (NYSE:AIZ), Tarena International, Inc eMarketsDaily
Traders Stocks Alert: ImmunoCellular Therapeutics Ltd (NYSEAMEX:IMUC Market News Call

all 13 news articles

…read more

Scroll to Top